Skip to main content

Advertisement

Table 1 Baseline characteristics of patients according to treatment arms with Plasmodium falciparum and Plasmodium vivax infections

From: Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea

Characteristics P. falciparum (N = 274) P. vivax (N = 70)
AL DHA-PPQ P-value AL DHA-PPQ P-value
Males (%) 48 52 0.74 40 60 > 0.99
Mean age (years) 6.5 8.2 0.04 4.5 4.0 0.53
Mean weight (kg) 18.7 19.9 0.33 15.2 14.0 0.53
Mean MUAC (cm) 17.2 17.5 0.48 16.5 16.5 > 0.95
Parasite density/µL
 Median 13,639 26718 < 0.0001 2835 6302 0.07
 Range 1058–26,373 1133–261,992   831–157,339 305–86,666  
 Mean temperature (°C) 37.8 37.5 0.08 37.7 36.9 0.009
 Enlarge spleen (%) 48.7 51.3 0.65 47.4 52.6 0.59
 Mean Hb (g/dL) 9.5 9.5 >0.95 9.7 9.5 0.58
  1. AL artemether–lumefantrine, DHA-PPQ dihydroartemisinin–piperaquine